Literature DB >> 10903872

Mutational analysis and NMR studies of the death domain of the tumor necrosis factor receptor-1.

J B Telliez1, G Y Xu, J D Woronicz, S Hsu, J L Wu, L Lin, S F Sukits, R Powers, L L Lin.   

Abstract

Tumor necrosis factor receptor-1 (TNFR-1) death domain (DD) is the intracellular functional domain responsible for the receptor signaling activities. To understand the transduction mechanism of TNFR-1 signaling we performed structural and functional analysis of the TNFR-DD. The secondary structure of the TNFR-DD shows that it consists of six anti-parallel alpha-helices. The determination of the topological fold and an extensive mutagenesis analysis revealed that there are two opposite faces that are involved in self-association and interaction with the TRADD death domain. Interestingly, the same critical residues in TNFR-DD are involved in both interactions. There is a good correlation between the binding activities of the mutant proteins and their cytotoxic activities. These results provide important insight into the molecular interactions mediating TNFR-DD self-association and subsequent recruitment of TRADD in the signaling activity of TNFR-1. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903872     DOI: 10.1006/jmbi.2000.3899

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

Review 1.  The death domain superfamily in intracellular signaling of apoptosis and inflammation.

Authors:  Hyun Ho Park; Yu-Chih Lo; Su-Chang Lin; Liwei Wang; Jin Kuk Yang; Hao Wu
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

2.  Phospho-SXXE/D motif mediated TNF receptor 1-TRADD death domain complex formation for T cell activation and migration.

Authors:  Ying-Jie Guan; Zhe Zhang; Chen Yu; Li Ma; Weiling Hu; Li Xu; Jin-Song Gao; Chun-Shiang Chung; Lijuan Wang; Zhong-Fa Yang; Loren D Fast; Alicia S Chung; Minsoo Kim; Alfred Ayala; Shougang Zhuang; Shusen Zheng; Y Eugene Chin
Journal:  J Immunol       Date:  2011-07-01       Impact factor: 5.422

3.  The p55 tumour necrosis factor receptor TNFR1 contains a trans-Golgi network localization signal in the C-terminal region of its cytoplasmic tail.

Authors:  Helen Storey; Abigail Stewart; Peter Vandenabeele; J Paul Luzio
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

4.  Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis.

Authors:  Huyan Meng; Zhen Liu; Xingyan Li; Huibing Wang; Taijie Jin; Guowei Wu; Bing Shan; Dana E Christofferson; Chunting Qi; Qiang Yu; Ying Li; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-12       Impact factor: 11.205

5.  TNF receptor-1 (TNF-R1) ubiquitous scaffolding and signaling protein interacts with TNF-R1 and TRAF2 via an N-terminal docking interface.

Authors:  Jennifer L Terry Powers; Kimberly E Mace; Helen Parfrey; Shin-Je Lee; Gongyi Zhang; David W H Riches
Journal:  Biochemistry       Date:  2010-09-14       Impact factor: 3.162

6.  Recognition of ERK MAP kinase by PEA-15 reveals a common docking site within the death domain and death effector domain.

Authors:  Justine M Hill; Hema Vaidyanathan; Joe W Ramos; Mark H Ginsberg; Milton H Werner
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

7.  Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex.

Authors:  Hyun Ho Park; Emmanuelle Logette; Stefan Raunser; Solange Cuenin; Thomas Walz; Jurg Tschopp; Hao Wu
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

Review 8.  Endothelial activation: intracellular signaling pathways.

Authors:  Jordan S Pober
Journal:  Arthritis Res       Date:  2002-05-09

9.  Antagonistic TNF receptor one-specific antibody (ATROSAB): receptor binding and in vitro bioactivity.

Authors:  Fabian Richter; Timo Liebig; Eric Guenzi; Andreas Herrmann; Peter Scheurich; Klaus Pfizenmaier; Roland E Kontermann
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.